This inventor holds 4 USPTO granted patents. Top assignees: King Saud University, Other. Active years: 2016-2024.
Company Filing History:
3 out of 786 
1 out of 834,411 Years Active: 2016-2024
Title: Assem Barakat: Innovator in Cancer Treatment
Introduction
Assem Barakat is a prominent inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of 4 patents, Barakat is recognized for his work in the area of nanoformulations and their applications in oncology.
Latest Patents
Barakat's latest patents include a groundbreaking nanoformulation of spirooxindole and methods for treating hepatocellular carcinoma. This spirooxindole nanoformulation features a proniosome loaded with a spirooxindole derivative. The spirooxindole derivative comprises a compound known as Compound 4d, which acts as an MDM2-p53 inhibitor. These substituted spirooxindoles possess a benzylidine (styryl) arm and a complex fused ring system that is ideally suited for binding to the MDM2 protein. This binding interrupts the protein-protein interaction (PPI), which is crucial in cancer progression. Testing has shown that these compounds exhibit anti-cancer activity against various forms of cancer cells affecting humans.
Career Highlights
Throughout his career, Assem Barakat has worked at King Saud University, where he has contributed to various research initiatives. His work has focused on developing innovative solutions to combat cancer, showcasing his commitment to advancing medical science.
Collaborations
Barakat has collaborated with notable colleagues, including Mohammad Shahidul Islam and Abdullah Mohammed Al Majid. These partnerships have enhanced his research efforts and contributed to the success of his innovative projects.
Conclusion
Assem Barakat stands out as a dedicated inventor in the field of cancer treatment, with a focus on developing effective therapies through innovative nanoformulations. His contributions are paving the way for advancements in oncology and improving patient outcomes.